http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-446571-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1976-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-446571-A1
titleOfInvention A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF VIMBLASTIN, LEUROSIDINE AND LEUROCRISTINE.
abstract A procedure for the preparation of vinblastine, leurosidine and leurocristine derivatives of the formula: ** (See formula) ** or its pharmaceutically acceptable acid addition salts where R is NH-alq-X, NH-cycloalq- (C3-C8), NH-alq- (OH) 1-3 or N3, where alq is (C1-C6) alkyl, Am is NH2, NH-CH3 or N (CH3) 2 and X is hydrogen, cyano, phenyl, carboxyl, carboalkoxy- (C1-C3) or carboxamido; R1 is hydrogen or acetyl; R'' is hydrogen, (C1-C3) alkyl, formyl or (C1-C3) alkanoyl; and one of the radicals R'''or R''''is hydroxyl and the other is ethyl; whose process is characterized by reacting a compound of Formula I where R is NH-NH2, R'is hydrogen or acetyl and R'', R''' and R'''' are those defined above, with a nitrosating agent to form an azide and, if desired, react the azide with a compound of formula ** (See formula) ** where R2 is H or -CH3 and R3 is CH3, alq-X, cycloalq (C3-C8), alq-Am or alq (OH) 1-3, where alq is (C1-C6) alkyl and Am and X are the defined above and, if desired, react any of the products obtained above with a non-toxic organic or inorganic acid to form the acid addition salt of the product. (Machine-translation by Google Translate, not legally binding)
priorityDate 1973-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124516887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496896

Total number of triples: 35.